Insiders · SLXN

SLXN insider transactions

Silexion Therapeutics Corp (SLXN) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for SLXN

• 65d
  SEC Form 4 filed by Shirvan Mitchell

  4 - Silexion Therapeutics Corp (0002022416) (Issuer)
• 98d
  Director Noy Shlomo was granted 9,091 units of Ordinary Shares (SEC Form 4)

  4 - Silexion Therapeutics Corp (0002022416) (Issuer)
• 100d
  Director Alon Ruth was granted 9,091 units of Ordinary Shares, increasing direct ownership by 800% to 10,228 units (SEC Form 4)

  4 - Silexion Therapeutics Corp (0002022416) (Issuer)
• 100d
  CSO and CDO Shirvan Mitchell was granted 49,726 units of Ordinary Shares, increasing direct ownership by 5,069% to 50,707 units (SEC Form 4)

  4 - Silexion Therapeutics Corp (0002022416) (Issuer)
• 100d
  CFO and Secretary Horenshtein Hadar Mirit was granted 49,726 units of Ordinary Shares, increasing direct ownership by 11,840% to 50,146 units (SEC Form 4)

  4 - Silexion Therapeutics Corp (0002022416) (Issuer)
• 100d
  Chairman and CEO Hadar Ilan was granted 64,350 units of Ordinary Shares, increasing direct ownership by 5,740% to 65,471 units (SEC Form 4)

  4 - Silexion Therapeutics Corp (0002022416) (Issuer)
• 100d
  Director Abramov Dror Yosef was granted 9,091 units of Ordinary Shares, increasing direct ownership by 835% to 10,180 units (SEC Form 4)

  4 - Silexion Therapeutics Corp (0002022416) (Issuer)
• 100d
  Director Peled Amnon was granted 7,576 units of Ordinary Shares, increasing direct ownership by 1,146% to 8,237 units (SEC Form 4)

  4 - Silexion Therapeutics Corp (0002022416) (Issuer)
• 100d
  Director Lushi Avner was granted 9,091 units of Ordinary Shares (SEC Form 4)

  4 - Silexion Therapeutics Corp (0002022416) (Issuer)
• 127d
  Director Levin Ilan disposed of 5,550 units of Ordinary Shares and was granted 450,000 units of Ordinary Shares (SEC Form 4)

  4 - Silexion Therapeutics Corp (0002022416) (Issuer)
• 154d
  Director Abramov Dror Yosef was granted 794 units of Ordinary Shares (SEC Form 4)

  4 - Silexion Therapeutics Corp (0002022416) (Issuer)
• 154d
  Director Alon Ruth was granted 794 units of Ordinary Shares (SEC Form 4)

  4 - Silexion Therapeutics Corp (0002022416) (Issuer)
• 154d
  Director Noy Shlomo was granted 1,587 units of Ordinary Shares (SEC Form 4)

  4 - Silexion Therapeutics Corp (0002022416) (Issuer)
• 154d
  Director Lushi Avner was granted 1,587 units of Ordinary Shares (SEC Form 4)

  4 - Silexion Therapeutics Corp (0002022416) (Issuer)
• 154d
  Director Peled Amnon was granted 661 units of Ordinary Shares (SEC Form 4)

  4 - Silexion Therapeutics Corp (0002022416) (Issuer)
• 532d
  New insider Peled Amnon claimed no ownership of stock in the company (SEC Form 3)

  3 - Silexion Therapeutics Corp (0002022416) (Issuer)